Literature DB >> 26341367

Hugl-1 inhibits glioma cell growth in intracranial model.

Xuejiao Liu1,2, Dong Lu1,2, Peng Ma3, Huaqiang Liu3, Yuewen Cao3, Ben Sang3, Xianlong Zhu3, Qiong Shi1,2, Jinxia Hu1,2, Rutong Yu4,5, Xiuping Zhou6,7.   

Abstract

Drosophila lethal (2) giant larvae (lgl) has been reported as a tumor suppressor and could regulate the Drosophila hippo signaling. Human giant larvae-1(Hugl-1), one human homologue of Drosophila lgl, also has been reported to be involved in the development of some human cancers. However, whether Hugl-1 is associated with the pathogenesis of malignant gliomas remains poorly understood. In the present work, we examined the effect of Hugl-1 on glioma cell growth both in vitro and in vivo. Firstly, we found that Hugl-1 protein levels decreased in the human glioma tissues, suggesting that Hugl-1 is involved in glioma progression. Unfortunately, either stably or transiently over-expressing Hugl-1 did not affect glioma cell proliferation in vitro. In addition, Hugl-1 over-expression did not regulate hippo signaling pathway. Interestingly, over-expression of Hugl-1 not only inhibited gliomagenesis but also markedly inhibited cell proliferation and promoted the apoptosis of U251 cells in an orthotopic model of nude mice. Taken together, this study provides the evidence that Hugl-1 inhibits glioma cell growth in intracranial model of nude mice, suggesting that Hugl-1 might be a potential tumor target for glioma therapy.

Entities:  

Keywords:  Gliomas; Hippo; Hugl-1; Proliferation

Mesh:

Substances:

Year:  2015        PMID: 26341367     DOI: 10.1007/s11060-015-1901-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  36 in total

1.  Tumorigenesis: the origins of glioma.

Authors:  Gemma K Alderton
Journal:  Nat Rev Cancer       Date:  2011-08-24       Impact factor: 60.716

2.  Expression of Hugl-1 is strongly reduced in malignant melanoma.

Authors:  S Kuphal; S Wallner; C C Schimanski; F Bataille; P Hofer; S Strand; D Strand; A K Bosserhoff
Journal:  Oncogene       Date:  2006-01-05       Impact factor: 9.867

3.  Lgl1 activation of rab10 promotes axonal membrane trafficking underlying neuronal polarization.

Authors:  Tong Wang; Yang Liu; Xiao-Hui Xu; Cai-Yun Deng; Kong-Yan Wu; Ji Zhu; Xiu-Qing Fu; Miao He; Zhen-Ge Luo
Journal:  Dev Cell       Date:  2011-09-13       Impact factor: 12.270

4.  Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.

Authors:  Wesley M Konsavage; Sydney L Kyler; Sherri A Rennoll; Ge Jin; Gregory S Yochum
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

5.  Tumor microenvironment complexity: emerging roles in cancer therapy.

Authors:  Melody A Swartz; Noriho Iida; Edward W Roberts; Sabina Sangaletti; Melissa H Wong; Fiona E Yull; Lisa M Coussens; Yves A DeClerck
Journal:  Cancer Res       Date:  2012-03-13       Impact factor: 12.701

6.  Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model.

Authors:  Nils Ole Schmidt; Mateo Ziu; Giorgio Carrabba; Carlo Giussani; Lorenzo Bello; Yanping Sun; Karl Schmidt; Mitchel Albert; Peter Mcl Black; Rona S Carroll
Journal:  Clin Cancer Res       Date:  2004-02-15       Impact factor: 12.531

7.  Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer.

Authors:  Tetsushi Tsuruga; Shunsuke Nakagawa; Michiko Watanabe; Shin Takizawa; Yoko Matsumoto; Kazunori Nagasaka; Kenbun Sone; Haruko Hiraike; Yuichiro Miyamoto; Osamu Hiraike; Takeo Minaguchi; Katsutoshi Oda; Toshiharu Yasugi; Tetsu Yano; Yuji Taketani
Journal:  Oncol Res       Date:  2007       Impact factor: 5.574

8.  Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes.

Authors:  Romane M Auvergne; Fraser J Sim; Su Wang; Devin Chandler-Militello; Jaclyn Burch; Yazan Al Fanek; Danielle Davis; Abdellatif Benraiss; Kevin Walter; Pragathi Achanta; Mahlon Johnson; Alfredo Quinones-Hinojosa; Sridaran Natesan; Heide L Ford; Steven A Goldman
Journal:  Cell Rep       Date:  2013-05-30       Impact factor: 9.423

9.  Identification of novel genetic alterations in samples of malignant glioma patients.

Authors:  Vedrana Milinkovic; Jasna Bankovic; Miodrag Rakic; Tijana Stankovic; Milica Skender-Gazibara; Sabera Ruzdijic; Nikola Tanic
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

10.  The Drosophila lethal(2)giant larvae tumor suppressor protein is a component of the cytoskeleton.

Authors:  D Strand; I Raska; B M Mechler
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  13 in total

1.  Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor.

Authors:  Xiuping Zhou; Shao Xie; Shishuang Wu; Yanhua Qi; Zhaohao Wang; Hao Zhang; Dong Lu; Xu Wang; Yu Dong; Guanzheng Liu; Dongxu Yang; Qiong Shi; Wenbin Bian; Rutong Yu
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

2.  CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways.

Authors:  Xuejiao Liu; Yulong Chong; Yiming Tu; Ning Liu; Chenglong Yue; Zhenglei Qi; Huize Liu; Yao Yao; Hongmei Liu; Shangfeng Gao; Mingshan Niu; Rutong Yu
Journal:  J Hematol Oncol       Date:  2016-10-12       Impact factor: 17.388

3.  Failure of the PTEN/aPKC/Lgl Axis Primes Formation of Adult Brain Tumours in Drosophila.

Authors:  Simona Paglia; Manuela Sollazzo; Simone Di Giacomo; Dario de Biase; Annalisa Pession; Daniela Grifoni
Journal:  Biomed Res Int       Date:  2017-12-27       Impact factor: 3.411

4.  Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway.

Authors:  Shangfeng Gao; Lei Jin; Guangping Liu; Peng Wang; Zonghan Sun; Yujia Cao; Hengliang Shi; Xuejiao Liu; Qiong Shi; Xiuping Zhou; Rutong Yu
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

5.  miR-9a mediates the role of Lethal giant larvae as an epithelial growth inhibitor in Drosophila.

Authors:  Scott G Daniel; Atlantis D Russ; Kathryn M Guthridge; Ammad I Raina; Patricia S Estes; Linda M Parsons; Helena E Richardson; Joyce A Schroeder; Daniela C Zarnescu
Journal:  Biol Open       Date:  2018-01-26       Impact factor: 2.422

6.  MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.

Authors:  Xuejiao Liu; Chenglong Yue; Lin Shi; Guanzheng Liu; Qiyu Cao; Qianqian Shan; Yifeng Wang; Xiangyu Chen; Huan Li; Jie Wang; Shangfeng Gao; Mingshan Niu; Rutong Yu
Journal:  J Cell Mol Med       Date:  2020-05-25       Impact factor: 5.310

7.  Golgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas.

Authors:  Xu Wang; Zhaohao Wang; Yu Zhang; Yan Wang; Hao Zhang; Shao Xie; Peng Xie; Rutong Yu; Xiuping Zhou
Journal:  Cell Prolif       Date:  2019-05-16       Impact factor: 6.831

8.  β-catenin-mediated YAP signaling promotes human glioma growth.

Authors:  Yan Wang; Peng Pan; Zhaohao Wang; Yu Zhang; Peng Xie; Decheng Geng; Yang Jiang; Rutong Yu; Xiuping Zhou
Journal:  J Exp Clin Cancer Res       Date:  2017-09-29

9.  Loss of LLGL1 Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases.

Authors:  Alexander Desuki; Frank Staib; Ines Gockel; Markus Moehler; Hauke Lang; Stefan Biesterfeld; Annett Maderer; Peter R Galle; Martin R Berger; Carl C Schimanski
Journal:  Can J Gastroenterol Hepatol       Date:  2019-04-01

10.  Targeted therapy of intracranial glioma model mice with curcumin nanoliposomes.

Authors:  Ming Zhao; Mengnan Zhao; Chen Fu; Yang Yu; Ailing Fu
Journal:  Int J Nanomedicine       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.